Health
NHS set to pilot GRAIL’s wide-ranging cancer blood test – PMLiVE
Previous study indicates test can detect over 50 cancer types
The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood test in 165,000 patients.
The Galleri blood test will be offered to 165,000 patients by NHS England in a new programme aimed at detecting early stage cancers.
The blood test identifies signs of a range of cancer types by searching for small fragments of DNA and RNA from tumours in the bloodstream to determine the presence of cancer.
The NHS will identify programme participants…
-
Noosa News10 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News12 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News5 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
General24 hours agoCatholic Education Tasmania to close six schools, with three others partially closed, due to coloured sand recall